single invest

Akthelia Pharmaceuticals

Akthelia has developed a new method for fighting infections using new compounds which act by stimulating the production of naturally occurring antimicrobial peptides (AMPs) in the body.

Akthelia Pharmaceuticals has been a part of the Accelerace accelerator program, that help startup companies accelerate and scale up their business model and finetune their companies. Akthelia Pharmaceuticals is one of more than 500 companies that Accelerace already have accelerated.

Related startups